NCT01733186: A trial that was reported late by Medipost Co Ltd.
This trial has reported, although it was 357 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01733186 |
|---|---|
| Title | Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects: A Phase I/IIa Clinical Trial in Patients With Focal, Full-thickness Grade 3-4 Articular Cartilage Defects of the Knee |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 7, 2013 |
| Completion date | June 2, 2017 |
| Required reporting date | June 2, 2020, midnight |
| Actual reporting date | May 25, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 357 |